Form 8-K PLAINS ALL AMERICAN PIPE For: May 03
0001070423falsePLAINS ALL AMERICAN PIPELINE LP00010704232024-05-032024-05-03UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934Date of Report (Date of earliest event reported) — May 3, 2024Plains All American Pipeline, L.P.(Exact name of registrant as specified in its charter)Delaware1-1456976-0582150(State or other jurisdiction ofincorporation)(Commission File... (continue reading...)
Form 6-K DR REDDYS LABORATORIES For: May 03
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
April, 2024
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Form 4 COMPASS Pathways plc For: May 01 Filed by: Jenkins Annalisa
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 144 MYOMO, INC. Filed by: Kovelman Harry
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
More SEC Filings
View Older Stories-
Form 13F-HR GSA CAPITAL PARTNERS For: Mar 31
-
Form 10-Q HERSHEY CO For: Mar 31
-
Form 10-Q PLEXUS CORP For: Mar 30
-
Form DEFA14A Catalent, Inc.
-
Form 6-K Haoxi Health Technology For: May 03
-
Form 4 Harmony Biosciences Hold For: May 01 Filed by: Budur Kumar
-
Form 10-Q CUMULUS MEDIA INC For: Mar 31
-
Form 10-Q SHENANDOAH TELECOMMUNICA For: Mar 31
-
Form ARS Foghorn Therapeutics For: Dec 31
-
Form 8-K CUMULUS MEDIA INC For: May 03
-
Form 424B2 BofA Finance LLC
-
Form 10-Q Shake Shack Inc. For: Mar 27
-
Form 10-Q SCI Engineered Materials For: Mar 31
-
Form DEFA14A Foghorn Therapeutics
-
Form 8-K Digital Brands Group, For: Apr 30
-
Form SC TO-I/A Evanston Alternative Filed by: Evanston Alternative Opportunities Fund
-
Form 8-K AMERICAN AXLE & MANUFACT For: May 03
-
Form 8-K Catalent, Inc. For: May 02
-
Form S-3ASR Keros Therapeutics, Inc.
-
Form 8-K Cidara Therapeutics, For: May 03
-
Form DEF 14A Foghorn Therapeutics For: Jun 26
-
Form 8-K Sonnet BioTherapeutics For: May 02
-
Form 8-K/A HOLOGIC INC For: May 02
-
Form 8-K Harmony Biosciences Hold For: May 01
-
Form 6-K Immuron Ltd For: May 03
-
Form DEF 14A SeaStar Medical Holding For: May 03
-
Form N-CSRS Columbia Funds Series For: Feb 29
-
Form 13F-HR COWEN AND COMPANY, LLC For: Mar 31
-
Form 8-K IES Holdings, Inc. For: May 03
-
Form 8-K Perella Weinberg Partner For: May 03
-
Form 10-Q ONESPAWORLD HOLDINGS For: Mar 31
-
Form N-CSR Columbia Funds Series For: Feb 29
-
Form D 42 North Private Holding
-
Form 10-Q IES Holdings, Inc. For: Mar 31
-
Form 10-Q TELEPHONE & DATA SYSTEMS For: Mar 31
-
Form 8-K/A TALOS ENERGY INC. For: Mar 04
-
Form DEFA14A HALLIBURTON CO
-
Form S-8 Burke & Herbert Financia
-
Form 10-Q HOLOGIC INC For: Mar 30
-
Form 6-K MAGNA INTERNATIONAL INC For: Mar 31
-
Form 8-K HALLIBURTON CO For: May 02
-
Form 10-Q Federal Home Loan Bank For: Mar 31
-
Form 10-Q UNITED STATES CELLULAR For: Mar 31
-
Form DEFA14A CROWN CASTLE INC.
-
Form 8-K CHART INDUSTRIES INC For: May 03
-
Form DEFA14A CROWN CASTLE INC.
-
Form 8-K TELEPHONE & DATA SYSTEMS For: May 03
-
Form 8-K fuboTV Inc. /FL For: May 03
-
Form 10-Q Fulgent Genetics, Inc. For: Mar 31
-
Form 8-K UNITED STATES CELLULAR For: May 03
